Le Lézard
Classified in: Business, Covid-19 virus
Subjects: ECO, POL, PSF, CFG

Prime Minister announces new partnerships with Canadian industries to fight COVID-19


OTTAWA, March 31, 2020 /CNW/ - Canadian businesses and manufacturers are stepping up to fight the COVID-19 pandemic. The Government of Canada is working with these companies to ensure our health care workers have the tools they need to care for Canadians across the country.

The Prime Minister, Justin Trudeau, today announced progress under Canada's Plan to Mobilize Industry to fight COVID-19, which increases Canada's ability to respond to the outbreak with necessary medical equipment and supplies.

The Government of Canada is investing $2 billion to support diagnostic testing and to purchase ventilators and protective personal equipment, including for bulk purchases with provinces and territories. Personal protective equipment includes things like more masks and face shields, gowns, and hand sanitizer.

On March 20, 2020, the Government of Canada called on Canadian businesses and manufacturers to help deliver critical health supplies. Since then, the government has spoken directly with almost 3,000 Canadian companies that have offered their expertise and capacity to meet the country's need for personal protective equipment and critical health supplies.

The Government of Canada has signed new procurement agreements with Canadian companies Thornhill Medical, Medicom, and Spartan Bioscience to purchase and boost capacity to manufacture equipment and supplies including portable ventilators, surgical masks, and rapid testing kits. The government has ordered millions of supplies to ease the pressure on health care facilities. It has also signed letters of intent with five companies ? Precision Biomonitoring, Fluid Energy Group Ltd., Irving Oil, Calko Group, and Stanfield's ? to produce additional test kits, hand sanitizer, and protective apparel including masks and gowns.

The government welcomes the cooperation of other companies and industries that have answered the call to action and offered their support in the fight against the COVID-19 pandemic. This includes efforts from companies to re-tool their facilities and double their production capacity, to collect and donate existing supplies and equipment, and to combine resources to manufacture needed supplies more quickly. Companies like Magna, General Motors, Toyota Motor Manufacturing Canada, Ford, Linamar, Shell, Suncor, Alibaba Group, and The Home Depot have helped Canada's health care professionals by donating personal protective and safety equipment and sanitizing supplies.

In addition, $50 million has been made available in funding for members of the Next Generation Manufacturing Supercluster to develop and scale-up new, in-demand technologies, equipment, and medical products. This includes technologies and products to test and treat Canadians, such as novel virus detection tests, vaccines, therapeutics, and symptom management treatments. It also includes medical equipment to care for Canadians, such as ventilators, peripherals, personal protective equipment, and cleaning and sterilization chemicals and equipment.

These measures are part of the larger strategy the Government of Canada is implementing to protect Canadians and prevent the spread of the virus. Collaboration with Canadian manufacturing and innovation is an important part of this strategy, which will ultimately result in better health and safety for Canadians, as well as a more resilient health care system.

Quote
"Canadian companies are answering the call to provide critical support to our health care workers, who are on the front lines of our country's fight against COVID-19. As the situation continues to evolve, the Government of Canada will be there to work with Canadian industry to find solutions that will support our medical professionals and protect the health and safety of all Canadians."
?The Rt. Hon. Justin Trudeau, Prime Minister of Canada

"Our government is mobilizing its resources to confront COVID-19, and Canadian industry is doing their part. We are in this together. From researchers to business there is a coordinated effort to protect the health and safety of Canadians. Today's announcement will help strengthen our country's response to COVID-19, while reinforcing our preparedness in responding to future health challenges."
?The Hon. Navdeep Bains, Minister of Innovation, Science and Industry

"We are taking an aggressive, proactive procurement approach to secure life-saving equipment and supplies. Industry has answered the call and we have successfully tapped into both existing and new supply sources. As a result, we have placed orders for millions of essential supplies in the fight against COVID-19."
?The Hon. Anita Anand, Minister of Public Services and Procurement

Quick Facts

Related Product

Associated Links

This document is also available at https://pm.gc.ca/

SOURCE Prime Minister's Office


These press releases may also interest you

at 08:05
Gilead Sciences, Inc. and Arcus Biosciences, Inc. today announced new data from Cohort B of ARC-9, a Phase 1b/2 study evaluating the safety and efficacy of etrumadenant, a dual A2a/b adenosine receptor antagonist, plus anti-PD-1 monoclonal antibody...

at 08:05
Detailed positive results from the DESTINY-Breast06 phase 3 trial showed that ENHERTU® (trastuzumab deruxtecan) demonstrated a statistically significant and clinically meaningful improvement in progression-free survival (PFS) compared to standard of...

at 08:05
Detailed positive results from the DESTINY-Breast06 Phase III trial showed that ENHERTU® (fam-trastuzumab deruxtecan-nxki) demonstrated a statistically significant and clinically meaningful improvement in progression-free survival (PFS) compared to...

1 jun 2024
Long-Term Follow-Up Data Signal Promising Progression-Free Survival (PFS) for Selinexor in the Maintenance Setting with Median PFS of 28.4 Months in the TP53 Wild-Type and 39.5 Months in the Proficient Mismatched Repair Status (pMMR) TP53 Wild-Type...

1 jun 2024
Taseko Mines Limited (LSE: TKO) ("Taseko" or the "Company") announced today that operations at the Company's Gibraltar Mine have been suspended. Collective bargaining with Gibraltar's union representatives has been ongoing in recent weeks, and...

1 jun 2024
Takeda (TSE:4502/NYSE:TAK) and Pfizer today announced that the German Hodgkin Study Group (GHSG) will present positive results from the Phase 3 HD21 trial evaluating ADCETRIS® (brentuximab vedotin) in combination with chemotherapy as a late-breaking...



News published on and distributed by: